Poole Lauren G, Wei Zimu, Schulte Anthony, Cline Holly M, Bernard Matthew P, Buchweitz John P, McGill Mitchell R, Luyendyk James P
Department of Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, United States.
Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.
Toxicol Sci. 2025 Jun 1;205(2):417-427. doi: 10.1093/toxsci/kfaf037.
Macrophages displaying a pro-repair and anti-inflammatory polarization have been implicated in resolution of acute liver injury. Macrophage receptor with collagenous structure (MARCO) expression marks tolerogenic hepatic macrophages and is expressed by pro-resolution macrophages in the injured liver. We tested the hypothesis that MARCO promotes repair of the acetaminophen (APAP)-injured liver. Robust and sustained induction of MARCO mRNA and protein expression was evident in livers of mice challenged with a hepatotoxic dose of APAP (i.e. 300 mg/kg), whereas hepatic MARCO induction failed in mice with APAP-induced liver failure (i.e. 600 mg/kg). Serum proteomics identified a significant increase in serum MARCO levels in surviving acute liver failure (ALF) patients, but not in ALF patients who died. MARCO expression was high in F480+ liver macrophages, and MARCO deficiency reduced macrophage expression of pro-resolution markers such as Gpnmb and Mertk during the repair phase (i.e. 48 h). The results suggested a delay in necrosis resolution along with a trend toward increased mortality in APAP-challenged MARCO-/- mice. Notably, a robust increase in peak hepatic injury (i.e. 6- to 24-h post-APAP challenge) was evident in MARCO-/- mice, which could not be ascribed to differences in NAPQI/APAP-adduct generation nor changes in hepatic neutrophil/macrophage numbers. Interestingly, a reduction in hepatic CD11c+ cells, shown previously to limit APAP-induced liver injury, was evident 24 h after APAP challenge in MARCO-/- mice. The results indicate that MARCO deficiency worsens APAP-induced acute liver injury in mice and provide experimental and initial translational evidence linking MARCO induction to positive outcomes in acute liver injury.
表现出促修复和抗炎极化的巨噬细胞与急性肝损伤的消退有关。具有胶原结构的巨噬细胞受体(MARCO)的表达标志着耐受性肝巨噬细胞,并且在受损肝脏中由促消退巨噬细胞表达。我们测试了MARCO促进对乙酰氨基酚(APAP)损伤肝脏修复的假设。在用肝毒性剂量的APAP(即300mg/kg)攻击的小鼠肝脏中,MARCO mRNA和蛋白表达有明显的强烈且持续的诱导,而在APAP诱导的肝衰竭小鼠(即600mg/kg)中,肝脏MARCO诱导失败。血清蛋白质组学显示,存活的急性肝衰竭(ALF)患者血清MARCO水平显著升高,但死亡的ALF患者则没有。MARCO在F480+肝巨噬细胞中表达较高,并且在修复阶段(即48小时),MARCO缺陷降低了促消退标志物如Gpnmb和Mertk的巨噬细胞表达。结果表明,在受到APAP攻击的MARCO-/-小鼠中,坏死消退延迟且死亡率有增加趋势。值得注意的是,MARCO-/-小鼠肝脏损伤峰值(即APAP攻击后6至24小时)有明显的强烈增加,这不能归因于NAPQI/APAP加合物生成的差异或肝脏中性粒细胞/巨噬细胞数量的变化。有趣的是,在APAP攻击24小时后,MARCO-/-小鼠肝脏中先前显示可限制APAP诱导的肝损伤的CD11c+细胞减少明显。结果表明,MARCO缺陷会加重小鼠APAP诱导的急性肝损伤,并提供了将MARCO诱导与急性肝损伤的积极结果联系起来的实验和初步转化证据。